Could Trump's new drug plan give new life to the Competitive Acquisition Program?
Tuesday, May 29th at NOON ET
Please join McGivney Global Advisors' (McGA) Jennifer Hinkel, MSc, and Jon Larsen JD, MPP, for a discussion with Timothy Tyler, PharmD, FCSHP, FHOPA, Director of Pharmacy, Lab, & Oncology Supportive Care at Desert Regional Medical Center to explore the recent Health and Human Services proposal to bring back a new iteration of the Competitive Acquisition Program (CAP) as an alternative to buy-and-bill for Part B drugs.
Webinar Goals include:
Understand the historical context of the original Competitive Acquisition Program (CAP) and related concerns and challenges
Hear direct practice perspectives on CAP from previous experience and thoughts on potential improvements to better serve patients
Discuss practice considerations for participating or not in a revamped CAP
Briefly discuss other HHS proposals impacting Part B, including ideas to move certain Part B drugs to Part D
